Rocket One Inc.
Rocket One, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in Hoboken, NJ.
CEO: Robb Knie - https://www.hoththerapeutics.com
HOTH vs S&P500
No data available.
Earnings per share
No data available.
Financials
No data available.
Cash / Debt
No data available.
Free Cash Flow
No data available.
Earnings Per Share (annual)
No data available.
Sales
No data available.